1. Home
  2. SITE vs GPCR Comparison

SITE vs GPCR Comparison

Compare SITE & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SITE

SiteOne Landscape Supply Inc.

HOLD

Current Price

$148.12

Market Cap

5.4B

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$78.30

Market Cap

6.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SITE
GPCR
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Professional and commerical equipment
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.3B
IPO Year
2016
2023

Fundamental Metrics

Financial Performance
Metric
SITE
GPCR
Price
$148.12
$78.30
Analyst Decision
Buy
Strong Buy
Analyst Count
11
12
Target Price
$150.10
$103.09
AVG Volume (30 Days)
682.4K
1.3M
Earning Date
02-11-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.08
N/A
Revenue
$4,672,300,000.00
N/A
Revenue This Year
$5.87
N/A
Revenue Next Year
$4.47
N/A
P/E Ratio
$48.75
N/A
Revenue Growth
4.00
N/A
52 Week Low
$101.25
$13.22
52 Week High
$154.00
$94.90

Technical Indicators

Market Signals
Indicator
SITE
GPCR
Relative Strength Index (RSI) 58.87 50.11
Support Level $139.82 $72.10
Resistance Level $152.23 $92.06
Average True Range (ATR) 4.02 4.34
MACD -0.27 -2.65
Stochastic Oscillator 60.50 29.97

Price Performance

Historical Comparison
SITE
GPCR

About SITE SiteOne Landscape Supply Inc.

SiteOne Landscape Supply Inc is a supplier of tools and equipment. The company serves various businesses which include wholesale irrigation, outdoor lighting, nursery, landscape supplies, grass seeds, and fertilizers, turf protection products, turf care equipment, and golf course accessories for green industry professionals mainly in the United States and Canada. Its product portfolio includes irrigation supplies, fertilizer and herbicides, landscape accessories, nursery goods, natural stones and blocks, outdoor lighting and ice melt products and other products.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: